Covid-19 population lockdowns may worsen socioeconomic inequities disproportionately impacting racial minorities: Machine learning-augmented cost effectiveness and computational ethical analysis with personalist social contract

Main Article Content

Dominique J. Monlezun, Dr.
https://orcid.org/0000-0001-7671-1886
Claudia Sotomayor, Dra.
https://orcid.org/0000-0001-7408-5180
Nathan J. Peters, Dr.
https://orcid.org/0000-0002-8207-6978
Colleen M. Gallagher, Dra.
https://orcid.org/0000-0003-1100-726X
Alberto García, Dr.
https://orcid.org/0000-0001-9090-0966
Cezar Iliescu, Dr.
https://orcid.org/0000-0002-8817-4579

Abstract




The novel coronavirus disease of 2019 (Covid-19) produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic creating a growing global health crisis given its novelty, scope, and initially limited efficacious treatment options. Yet little is known about optimal non-pharmaceutical interventions to improve its morbidity and mortality, particularly their cost effectiveness and ethical aspects. This is thus the first known machine learning-augmented cost effectiveness and ethical analysis of Covid-19 containment measures (and of population quarantine measures in particular for any pandemic) to assist health systems and governments in ensuring the most clinically and cost-effective care that can be equitably provided to as many patients as possible during this pandemic and future similar global crises. This analysis utilized the methodology adopted by the Centers for Disease Control and Prevention (CDC), commonly accepted figures as inputs, and both extreme and real-world minimal assumptions to provide the most robust and reliable results possible. Cost analysis indicated that in the extreme or best-case scenarios for the Covid-19 containment measure of population quarantine, there is a cost-effectiveness ratio of $154.86 million spent per averted death and a net cost of $1.92 trillion globally. In real-world scenarios, this intervention has a ratio of $2.52 billion spent per averted death for a net cost of $1.99 trillion. Personalist social contract ethics as articulated by the United Nations’ popular ethical system of rights and duties highlights the particular concerns that such lockdowns may be unethical injustices perpetuated by states in a manner that undermine individual lives and liberties while disproportionately negatively impacting lower income communities particularly racial minorities. This study thus suggests that the prevalent practice of population quarantine compared to standard precautions and more targeted interventions may provide inadequate net benefit for its financial and ethical cost. At a time of global shortages straining health system capacities to adequately detect and care for Covid-19 patients particularly in developing nations and underserved communities, this study supports focusing resources less on interventions with unclear benefit-cost trade-off and more on better affordable, ethical, and equitable interventions with greater evidence for their life-saving net benefits.




Downloads

Download data is not yet available.

PLUMX Metrics

Article Details

How to Cite
Monlezun, D. J., Sotomayor, C., Peters, N. J., Gallagher, C. M., García A., & Iliescu, C. (2021). Covid-19 population lockdowns may worsen socioeconomic inequities disproportionately impacting racial minorities: Machine learning-augmented cost effectiveness and computational ethical analysis with personalist social contract. Revista De Medicina Y Ética, 32(3), 759–800. https://doi.org/10.36105/mye.2021v32n3.04
Section
Articles

References

1. Ferguson NM, Laydon D, Nedjati-Gilan G, et alt. Impact of non-pharmaceutical interventions to reduce Covid-19 mortality and healthcare demand. London: Impe- rial College, 2020. Disponible en: https://www.imperial.ac.uk/media/imperial-colle- ge/medicine/mrc-gida/2020-03-16-COVID19-Report-9.pdf https://doi.org/10.15420/aer.2017.40.3
2. Mintz M. Covid-19 Daily update: April 17, 2020. S&P Global. (Consultado el 17 de abril de 2020). Disponible en: https://www.spglobal.com/en/research-insights/arti- cles/covid-19-daily-update-april-14-2020 https://doi.org/10.26524/royal.37.6
3. Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-Pharmaceutical public health interventions for pandemic influenza: An evaluation of the evidence base. BMC Public Health. 2007; 7: 208. https://doi.org/10.1186/1471-2458-7-208
4. Nussbaumer-Streit B, Mayr V, Dobrescu AI, et. al. Quarantine alone or in combi- nation with other public health measures to control Covid 19: A rapid review. Co- chrane Database Systematic Reviews. 8 de abril de 2020; 4: CD013574. https://doi.org/10.1002/14651858.cd013574
5. Ioannidis JPA. Coronavirus disease 2019: The harms of exaggerated informa- tion and non-evidence-based measures. European Journal of Clinical Investiga- tion. 23 de marzo de 2020; e13223. https://doi.org/10.1111/eci.13223
6. Galea S, Tracy M, Hoggatt JK, Dimaggio C, Karpati A. Estimated deaths attribu- table to social factors in the United States. American Journal of Public Health. Agosto de 2011; 101(8): 1456-65. https://doi.org/10.2105/AJPH.2010.300086
7. Parmet WE, Sinha MS. Covid-19, the law and limits of quarantine. The New En- gland Journal of Medicine. 2020. https://doi.org/10.1056/NEJMp2004211
8. Russell LB, Sinha A. Strengthening cost-effectiveness analysis for public health policy. American Journal of Preventive Medicine. 2016; 50(5): S6-S12. https://doi.org/10.1016/j.amepre.2015.11.007
9. HME. Covid-19 health service utilization forecasting team. Forecasting Covid-19 impact on hospital bed-days, ICU-days, ventilator days and deaths by US State in the next 4 months. MedRxiv. 26 de marzo de 2020. https://doi.org/10.1101/2020.03.27.20043752
10. Boston Children’s Hospital HealthMap. Boston, MA: Covid-19, 2020. https://www.healthmap.org/covid-19
11. The United Nations. Universal Declaration of Human Rights. 1948. (Consulta- do el 6 de noviembre de 2020). Disponible en: https://www.un.org.
12. Nature. Why do Covid-19 death rates seem to be falling? (Consultado el 11 de noviembre de 2020). Disponible en: https://www.nature.com/articles/d41586-020- 03132-4
13. Monlezun DJ. The global bioethics of artificial intelligence and human rights. Cambridge Scholars Publishing, 2020.
14. García A, Lunstroth J, Monlezun DJ, Sotomayor CR. Convergence of human rights and duties: Towards a global bioethics. In: Tham J, Kwan K, García A (eds). Religious perspectives on bioethics and human rights. Advancing Global Bio- ethics, vol 6. Springer, Cham. https://doi.org/10.1007/978-3-319-58431-7_4
15. Monlezun DJ. Getting (human) value-based payments right: Neuroeconomic personalism in Thomistic-influenced human rights and duties-based global bio- ethics (THRD-GB). Journal of Medicine and the Person. 2015; 13(2): 135-136. https://doi.org/10.1007/s12682-015-0209-6
16. Pew Research Center. The changing global religious landscape. 2017. (Con- sultado el 6 de noviembre de 2020). Disponible en: https://www.pewforum.org
17. Rómulo, Carlos. «Natural law and international law» in Natural Law Institute proceedings, Vol. 3, Edward Barrett (ed.). South Bend: University of Notre Dame Press. 1950.
18. Smith S. Aristotle’s Logic. In: Zalta EN (ed.) The Stanford Encyclopedia of Phi- losophy: Fall 2020 Edition. Stanford University, 2020. (Consultado el 6 de noviem- bre de 2020). Disponible en: https://plato.stanford.edu/archives/fall2020/entries/ aristotle-logic
19. Orlik T, Rush J, Cousin M, Hong J. Coronavirus could cost the global economy $2.7 trillion. Bloomberg. (Consultado el 17 de abril de 2020). Disponible en: https:/ /www.bloomberg.com/graphics/2020coronaviruspandemicglobaleconomicrisk/
20. The Coronavirus shock: A story of another global crisis foretold and what poli- cymakers should be doing about it. Geneva: United Nation Conference on Trade and Development, 2020. Disponible en: https://unctad.org/system/files/official-docu- ment/gds_tdr2019_update_coronavirus.pdf https://doi.org/10.18356/4845ca36-en 21. Covid-19 Test Pricing. Baltimore: US Centers for Medicare & Medicaid Servi- ces, 2020. Disponible en: https://www.cms.gov
22. Guidelines for Preparing Economic Analyses. Washington, DC: US Environ- mental Protection Agency, 2010. Disponible en: https://www.epa.gov
23. Meyerowitz-Katza G, Meronec L. A systematic review and meta-analysis of pu- blished research data on Covid-19 infection fatality rates. Int J Infect Dis. Diciem- bre de 2020; 101: 138-148. https://doi.org/10.1016/j.ijid.2020.09.1464
24. United Nations. Covid-19 to slash global economic output by $8.5 trillion over next two years. (Consultado el 13 de mayo de 2020). Disponible en: https://www.- un.org/development/desa/en/news/policy/wesp-mid-2020-report.html
25. World Bank. Covid-19 to Plunge Global Economy into Worst Recession since World War II. (Consultado el 8 de junio de 2020). Disponible en: https://www.world- bank.org/en/news/press-release/2020/06/08/covid-19-to-plunge-global-economy- into-worst-recession-since-world-war-ii https://doi.org/10.36880/c12.02467
26. Global spending on health: a world in transition. Geneva: World Health Orga- nization; 2019. (WHO/HIS/HGF/HFWorkingPaper/19.4). License: CC BY-NC-SA 3.0 IGO. 27. Khazanchi R, Evans CT, Marcelin JR. Racism, not race, drives inequity across the covid-19 continuum. JAMA. 2020. https://doi.org/10.1001/jamanetworkopen.2020.19933
28. Boyd RW, Lindo EG, Weeks LD, McLemore MR. On racism: A new standard for publishing on racial health inequities. Health Affairs. 2020. Disponible en: https://www.healthaffairs.org/do/10.1377/hblog20200630.939347/full/ https://doi.org/10.1377/hblog20200630.939347.
29. World Health Organization. Coronavirus disease (Covid-19): Herd immunity, lockdowns and Covid-19. (Consultado el 15 de octubre de 2020). Disponible en: https://www.who.int/news-room/q-a-detail/herd-immunity-lockdowns-and-covid-19 https://doi.org/10.2172/1659688
30. World Health Organization. Cardiovascular diseases. (Consultado el 11 de no- viembre de 2020). Disponible en: https://www. who.int/health-topics/cardiovascular- diseases/#tab=tab_1
31. Ioannidis JP. Infection fatality rate of Covid-19 inferred from seroprevalence data. World Health Organization Bulletin. (Consultado el 4 de octubre de 2020). Disponible en: https://www.who.int/bulletin/online_first/BLT.20.265892.pdf https://doi.org/10.2471/blt.20.265892